PRICES include / exclude VAT
Homepage>BS Standards>07 MATHEMATICS. NATURAL SCIENCES>07.100 Microbiology>07.100.30 Food microbiology>23/30479739 DC BS EN 18033 Food authenticity. Quantitation of equine DNA relative to mammalian DNA in raw beef (meat)
Sponsored link
immediate downloadReleased: 2023-11-09
23/30479739 DC BS EN 18033 Food authenticity. Quantitation of equine DNA relative to mammalian DNA in raw beef (meat)

23/30479739 DC

BS EN 18033 Food authenticity. Quantitation of equine DNA relative to mammalian DNA in raw beef (meat)

Format
Availability
Price and currency
English Secure PDF
Immediate download
24.00 EUR
English Hardcopy
In stock
24.00 EUR
Standard number:23/30479739 DC
Pages:17
Released:2023-11-09
Status:Draft for Comment
DESCRIPTION

23/30479739 DC


This standard 23/30479739 DC BS EN 18033 Food authenticity. Quantitation of equine DNA relative to mammalian DNA in raw beef (meat) is classified in these ICS categories:
  • 07.100.30 Food microbiology
  • 67.120.10 Meat and meat products
  • 07.100.30 Food microbiology
  • 67.120.10 Meat and meat products
This document specifies a real-time PCR procedure for the quantitation of the amount of equine DNA relative to total mammalian DNA in a raw meat sample. Results of this equine assay are expressed in terms of equine (Equus genus) haploid genome copy numbers relative to total mammalian haploid genome copy numbers. This assay is specific for representatives of the genus Equus and therefore detects horse, mule, donkey and zebra DNA. The method has been previously validated in a collaborative trial and applied to DNA extracted from samples that consist of raw horse meat in a raw beef (meat) background. The limit of detection has been determined experimentally to be at least 9 genomic equivalent copies (~ 17 haploid target gene copies) for both the horse genome (E. caballus) and mammalian genome (raw meat samples) based on the lowest dilution on the respective calibration curves through single laboratory validation. The lowest relative horse content of the target sequence included in the collaborative trial was a mass fraction of 0,1 % based on gravimetrically prepared raw horse muscle tissue in a raw beef muscle tissue background. The compliance assessment process is not part of this document.